, Tracking Stock Market Picks
Enter Symbol:
Human Genome Sciences, Inc. (HGSI) [hlAlert]

up 634.53 %

Human Genome Sciences, Inc. (HGSI) rated Buy with price target $5 by Stanford Research

Posted on: Wednesday,  Dec 10, 2008  9:25 AM ET by Stanford Research

Stanford Research rated Buy Human Genome Sciences, Inc. (NASDAQ: HGSI) on 12/10/2008, when the stock price was $1.94.
Since then, Human Genome Sciences, Inc. has gained 634.54% as of 08/01/2012's recent price of $14.25.
If you would have followed this Stanford Research's recommendation on HGSI, you would have gained 634.53% of your investment in 1330 days.

Human Genome Sciences is a biopharmaceutical company with a pipeline of novel compounds in clinical development, including drugs to treat such diseases as hepatitis C, lupus, anthrax disease, cancer, rheumatoid arthritis and HIV/AIDS. Additional products are in clinical development by companies with which we are collaborating. Its mission is to discover, develop, manufacture and market innovative drugs that serve patients with unmet medical needs, with a primary focus on protein and antibody products.

Stanford Research encompasses both institutional equity research and Washington-focused policy research, offering a perspective on individual companies, sector-specific topics and national policy. The importance Stanford Group Company places on research comes from years of experience in a constantly changing world. We know that as markets develop and new sectors grow, it is imperative that our clients have the most accurate information available to ensure financial success. Stanford Group Company clients will always have our commitment to conduct informative and enlightening research. As a part of our commitment to our clients, we provide objective, well-developed research. Our skilled analysts use their talent to provide invaluable research that can help in making important decisions. Thanks to a wide range of resources obtained through technology, experience and reputation, our research analysts develop reports on the most current firms and sectors. Our equity analysts offer insight and opinions on companies in the consumer/retail, media, energy, financial institutions, health care, technology and water/environment sectors.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/10/2008 9:25 AM Buy
1.94 5.00
as of 12/24/2008
1 Week down  -12.16 %
1 Month down  -38.67 %
3 Months   
1 YTD down  -38.67 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy